Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released May 5, 2017, after the close
10-Q filed May 5, 2017, 35 days after period end · 0001299130-17-000033
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $24.92M | $19.13M | $17.65M | $11.64M |
| Net Income | -$23.87M | -$19.35M | -$20.17M | -$18.89M |
| EPS Diluted | -$0.26 |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.23 |
| -$0.27 |
| -$0.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
